Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas L Gift

Showing results (101-110 of 162) with videos related to

Pageof 17
Sort By:
Plos Computational Biology|February 9, 2022
Evaluating spatially adaptive guidelines for the treatment of gonorrhea to reduce the incidence of gonococcal infection and increase the effective lifespan of antibioticsReza Yaesoubi, Ted Cohen, Katherine Hsu, et al.
Journal of Public Health Management and Practice : JPHMP|January 25, 2024
An Interactive Modeling Tool for Projecting the Health and Direct Medical Cost Impact of Changes in the Sexually Transmitted Diseases Prevention Program BudgetsErika G Martin, Bahareh Ansari, Thomas L Gift, et al.
JAMA Network Open|May 29, 2026
A Staff-Directed Electronic Medical Record Alert to Increase Chlamydia Screening: A Randomized Clinical TrialHarold C Wiesenfeld, Jaeyoung Hong, Tong Xu, et al.
Sexually Transmitted Diseases|October 1, 2020
Estimating Recommended Gonorrhea and Chlamydia Treatment Rate Using Linked Medical Claims, Prescription, and Laboratory Data in US Private SettingsGuoyu Tao, Kimberly Workowski, Katherine E Bowden, et al.
Sexually Transmitted Diseases|August 25, 2005
A cost-effectiveness analysis of interventions to increase repeat testing in patients treated for gonorrhea or chlamydia at public sexually transmitted disease clinicsThomas L Gift, C Kevin Malotte, Rebecca Ledsky, et al.
Sexually Transmitted Diseases|February 22, 2023
Costs, Health Benefits, and Cost-Effectiveness of Chlamydia Screening and Partner Notification in the United States, 2000-2019: A Mathematical Modeling AnalysisMinttu M Rönn, Yunfei Li, Thomas L Gift, et al.
Sexually Transmitted Diseases|January 11, 2023
Estimated Number of Incident HIV Infections in Men Who Have Sex With Men Attributable to Gonorrhea and Chlamydia, Per Gonococcal or Chlamydial Infection, in the United StatesJeb Jones, Samuel M Jenness, Adrien Le Guillou, et al.
Sexually Transmitted Diseases|March 14, 2025
Economic Outcomes of Disease Intervention Specialist-Delivered Interventions for Sexually Transmitted Infections: A Systematic ReviewErika G Martin, Arzana Myderrizi, Heeun Kim, et al.
Sexually Transmitted Diseases|March 15, 2006
Patient-delivered partner treatment for Trichomonas vaginalis infection: a randomized controlled trialPatricia Kissinger, Norine Schmidt, Hamish Mohammed, et al.
MMWR. Morbidity and Mortality Weekly Report|April 7, 2017
State-Specific Rates of Primary and Secondary Syphilis Among Men Who Have Sex with Men - United States, 2015Alex de Voux, Sarah Kidd, Jeremy A Grey, et al.
Pageof 17

Showing results (101-110 of 162) with videos related to

Sort By:
Pageof 17
Plos Computational Biology|February 9, 2022
Evaluating spatially adaptive guidelines for the treatment of gonorrhea to reduce the incidence of gonococcal infection and increase the effective lifespan of antibioticsReza Yaesoubi, Ted Cohen, Katherine Hsu, et al.
Journal of Public Health Management and Practice : JPHMP|January 25, 2024
An Interactive Modeling Tool for Projecting the Health and Direct Medical Cost Impact of Changes in the Sexually Transmitted Diseases Prevention Program BudgetsErika G Martin, Bahareh Ansari, Thomas L Gift, et al.
JAMA Network Open|May 29, 2026
A Staff-Directed Electronic Medical Record Alert to Increase Chlamydia Screening: A Randomized Clinical TrialHarold C Wiesenfeld, Jaeyoung Hong, Tong Xu, et al.
Sexually Transmitted Diseases|October 1, 2020
Estimating Recommended Gonorrhea and Chlamydia Treatment Rate Using Linked Medical Claims, Prescription, and Laboratory Data in US Private SettingsGuoyu Tao, Kimberly Workowski, Katherine E Bowden, et al.
Sexually Transmitted Diseases|August 25, 2005
A cost-effectiveness analysis of interventions to increase repeat testing in patients treated for gonorrhea or chlamydia at public sexually transmitted disease clinicsThomas L Gift, C Kevin Malotte, Rebecca Ledsky, et al.
Sexually Transmitted Diseases|February 22, 2023
Costs, Health Benefits, and Cost-Effectiveness of Chlamydia Screening and Partner Notification in the United States, 2000-2019: A Mathematical Modeling AnalysisMinttu M Rönn, Yunfei Li, Thomas L Gift, et al.
Sexually Transmitted Diseases|January 11, 2023
Estimated Number of Incident HIV Infections in Men Who Have Sex With Men Attributable to Gonorrhea and Chlamydia, Per Gonococcal or Chlamydial Infection, in the United StatesJeb Jones, Samuel M Jenness, Adrien Le Guillou, et al.
Sexually Transmitted Diseases|March 14, 2025
Economic Outcomes of Disease Intervention Specialist-Delivered Interventions for Sexually Transmitted Infections: A Systematic ReviewErika G Martin, Arzana Myderrizi, Heeun Kim, et al.
Sexually Transmitted Diseases|March 15, 2006
Patient-delivered partner treatment for Trichomonas vaginalis infection: a randomized controlled trialPatricia Kissinger, Norine Schmidt, Hamish Mohammed, et al.
MMWR. Morbidity and Mortality Weekly Report|April 7, 2017
State-Specific Rates of Primary and Secondary Syphilis Among Men Who Have Sex with Men - United States, 2015Alex de Voux, Sarah Kidd, Jeremy A Grey, et al.
Pageof 17